Improvement of the reverse tetracycline transactivator by single amino acid substitutions that reduce leaky target gene expression to undetectable levels

Conditional gene expression systems that enable inducible and reversible transcriptional control are essential research tools and have broad applications in biomedicine and biotechnology. The reverse tetracycline transcriptional activator is a canonical system for engineered gene expression control that enables graded and gratuitous modulation of target gene transcription in eukaryotes from yeast to human cell lines and transgenic animals. However, the system has a tendency to activate transcription even in the absence of tetracycline and this leaky target gene expression impedes its use. Here, we identify single amino-acid substitutions that greatly enhance the dynamic range of the system in yeast by reducing leaky transcription to undetectable levels while retaining high expression capacity in the presence of inducer. While the mutations increase the inducer concentration required for full induction, additional sensitivity-enhancing mutations can compensate for this effect and confer a high degree of robustness to the system. The novel transactivator variants will be useful in applications where tight and tunable regulation of gene expression is paramount.

[1]  B. Séraphin,et al.  Positive feedback in eukaryotic gene networks: cell differentiation by graded to binary response conversion , 2001, The EMBO journal.

[2]  G. Balázsi,et al.  Negative autoregulation linearizes the dose–response and suppresses the heterogeneity of gene expression , 2009, Proceedings of the National Academy of Sciences.

[3]  Jeff Hasty,et al.  Phenotypic impact of regulatory noise in cellular stress-response pathways , 2010, Systems and Synthetic Biology.

[4]  J. Pinkham,et al.  Tightly regulated, beta-estradiol dose-dependent expression system for yeast. , 2000, BioTechniques.

[5]  R. Cortese,et al.  Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates , 2003 .

[6]  G. Bellí,et al.  An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast. , 1998, Nucleic acids research.

[7]  H. Blau,et al.  Transcriptional control: rheostat converted to on/off switch. , 2000, Molecular cell.

[8]  Philipp S. Hoppe,et al.  Single-cell technologies sharpen up mammalian stem cell research , 2014, Nature Cell Biology.

[9]  J. Collins,et al.  DIVERSITY-BASED, MODEL-GUIDED CONSTRUCTION OF SYNTHETIC GENE NETWORKS WITH PREDICTED FUNCTIONS , 2009, Nature Biotechnology.

[10]  M. Manhart,et al.  Stress-response balance drives the evolution of a network module and its host genome , 2015, Molecular systems biology.

[11]  Lukas E Dow,et al.  Inducible in vivo genome editing with CRISPR/Cas9 , 2015, Nature Biotechnology.

[12]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[13]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[14]  Tsz-Leung To,et al.  Noise Can Induce Bimodality in Positive Transcriptional Feedback Loops Without Bistability , 2010, Science.

[15]  Mads Kærn,et al.  Noise in eukaryotic gene expression , 2003, Nature.

[16]  Mads Kærn,et al.  No training required: experimental tests support homology-based DNA assembly as a best practice in synthetic biology , 2015, Journal of biological engineering.

[17]  W. Saenger,et al.  Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. , 1994, Science.

[18]  M. Lotze,et al.  Second‐generation tetracycline‐regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness , 2004, The journal of gene medicine.

[19]  A. Das,et al.  Viral Evolution as a Tool to Improve the Tetracycline-regulated Gene Expression System* , 2004, Journal of Biological Chemistry.

[20]  R. Schiestl,et al.  High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method , 2007, Nature Protocols.

[21]  Benjamin B. Kaufmann,et al.  Contributions of low molecule number and chromosomal positioning to stochastic gene expression , 2005, Nature Genetics.

[22]  A. Das,et al.  Optimization of the Tet-On system for regulated gene expression through viral evolution , 2006, Gene Therapy.

[23]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Verhaagen,et al.  Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve , 2014, Gene Therapy.

[25]  A. Das,et al.  Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter , 2005, Nucleic acids research.

[26]  Erin K. Kennedy,et al.  A Wee1 checkpoint inhibits anaphase onset , 2013, The Journal of cell biology.

[27]  S Falkow,et al.  Yeast-enhanced green fluorescent protein (yEGFP): a reporter of gene expression in Candida albicans. , 1997, Microbiology.

[28]  M. Gossen,et al.  Improved Tet-responsive promoters with minimized background expression , 2010, BMC biotechnology.

[29]  S. Oliver,et al.  Doxycycline, the drug used to control the tet‐regulatable promoter system, has no effect on global gene expression in Saccharomyces cerevisiae , 2005, Yeast.

[30]  A. Das,et al.  Selecting the optimal Tet‐On system for doxycycline‐inducible gene expression in transiently transfected and stably transduced mammalian cells , 2016, Biotechnology journal.